SULFANILAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfanilamide, and when can generic versions of Sulfanilamide launch?
Sulfanilamide is a drug marketed by Cosette and is included in one NDA.
The generic ingredient in SULFANILAMIDE is sulfanilamide. There are six drug master file entries for this compound. Additional details are available on the sulfanilamide profile page.
Summary for SULFANILAMIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 174 |
Clinical Trials: | 1 |
Patent Applications: | 3,627 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFANILAMIDE at DailyMed |
Recent Clinical Trials for SULFANILAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shanxi Dayi Hospital | Phase 4 |
Jilin Provincial Tumor Hospital | Phase 4 |
Peking Union Medical College Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for SULFANILAMIDE
US Patents and Regulatory Information for SULFANILAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | SULFANILAMIDE | sulfanilamide | CREAM;VAGINAL | 088718-001 | Sep 19, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |